Weibin Hou
Impact in
-
- Renal cell carcinoma treatment
-
- Immune cells in cancer
Papers in
- Surgery 12
- Bladder and Urothelial Cancer Treatments 9
-
- Renal cell carcinoma treatment 6
- Renal and Vascular Pathologies 3
- Co-authors
- Weigang Yan (2 shared papers)Meihua Yang (5 shared papers)Tianxin Lin (6 shared papers)Wenlong Zhong (5 shared papers)Zhi Long (5 shared papers)Wei Xiang (6 shared papers)Jin Tang (6 shared papers)Jian Huang (5 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Urologic Oncology Seminars and Original Investigations (2 papers)Advanced Science (1 paper)Biomaterials Research (1 paper)Biomedicines (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Weibin Hou
31 papers receiving 304 citations
Peers
Comparison fields: 5 of 51
- Pulmonary and Respiratory Medicine 82
- Immunology 55
- Oncology 59
- Cancer Research 28
- Molecular Biology 95
Countries citing papers authored by Weibin Hou
This map shows the geographic impact of Weibin Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibin Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibin Hou more than expected).
Fields of papers citing papers by Weibin Hou
This network shows the impact of papers produced by Weibin Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibin Hou. The network helps show where Weibin Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Weibin Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 32 | |
| 2 | 2014 | 32 | |
| 3 | 2023 | 24 | |
| 4 | 2022 | 21 | |
| 5 | 2022 | 20 | |
| 6 | 2024 | 17 | |
| 7 | 2018 | 17 | |
| 8 | 2020 | 17 | |
| 9 | 2015 | 17 | |
| 10 | 2013 | 13 | |
| 11 | 2020 | 10 | |
| 12 | 2020 | 10 | |
| 13 | 2019 | 10 | |
| 14 | 2025 | 9 | |
| 15 | 2021 | 8 | |
| 16 | Human leukocyte antigen-G-14-base-pair-insertion/deletion polymorphism and graft survival in kidney transplant recipients. | 2014 | 7 |
| 17 | 2021 | 7 | |
| 18 | 2022 | 6 | |
| 19 | 2023 | 5 | |
| 20 | 2023 | 5 |
About Weibin Hou
Weibin Hou is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Immunology and Molecular Biology, having authored 33 papers that have together received 307 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Renal cell carcinoma treatment (6 papers), Renal and Vascular Pathologies (3 papers), Immune cells in cancer (3 papers), Immunotherapy and Immune Responses (3 papers), Nanoplatforms for cancer theranostics (3 papers) and Urological Disorders and Treatments (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (82 citations), Immunology (55 citations), Oncology (59 citations), Cancer Research (28 citations) and Molecular Biology (95 citations). Weibin Hou has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Weigang Yan, Meihua Yang, Tianxin Lin, Wenlong Zhong, Zhi Long, Wei Xiang, Jin Tang, Jian Huang, Hong Zeng and Bo Wang. Their work appears in journals such as Frontiers in Immunology, Urologic Oncology Seminars and Original Investigations, Advanced Science, Biomaterials Research and Biomedicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.